Elevated Lp(a) level has been linked to increased coronary artery calcium (CAC) score and progression of atherosclerosis in STAR-Lp(a) – a cohort study of 553 patients with risk factors for cardiovascular disease (CVD) but without evidence of disease.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
